Meeting Banner
Abstract #0724

T 1 and T 2 NMRD Studies of Angiomark™ (MS-325)

P. Caravan, J.W.M. Bulte, S.U. Dunham, J. Amedio and R.B. Lauffer, EPIX Medical Inc., Cambridge, MA, USA and National Institutes of Health, Bethesda, MD, USA.